Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification

BACKGROUND: Malignant pleural mesothelioma (MPM) is a rare and aggressive neoplasia affecting the lung mesothelium. Immune checkpoint inhibitors (ICI) in MPM have not been extremely successful, likely due to poor identification of suitable candidate patients for the therapy. We aimed to identify cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Alay, Ania, Cordero, David, Hijazo-Pechero, Sara, Aliagas, Elisabet, Lopez-Doriga, Adriana, Marín, Raúl, Palmero, Ramón, Llatjós, Roger, Escobar, Ignacio, Ramos, Ricard, Padrones, Susana, Moreno, Víctor, Nadal, Ernest, Solé, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908918/
https://www.ncbi.nlm.nih.gov/pubmed/33632900
http://dx.doi.org/10.1136/jitc-2020-001601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908918/
https://www.ncbi.nlm.nih.gov/pubmed/33632900
http://dx.doi.org/10.1136/jitc-2020-001601

Ejemplares similares